Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Recruiting

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Sponsor:

Tenaya Therapeutics

Code:

NCT05112237

Conditions

Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Tenaya Therapeutics on 2024-11-13.